Prof. Fatmah Alasmary | Pharmaceutical innovation | Best Researcher Award
Prof. Fatmah Alasmary, Saudi Food and Drug Authority, Saudi Arabia
Professor at King Saud University, specializing in organic chemistry. Dr. Alasmary has extensive experience in academia and leadership, with a PhD from the University of Bradford. Currently, she serves as Director of the Drug Lab at the Saudi Food and Drug Authority. Her research interests include antimicrobial agents and nanomaterials. Dr. Alasmary has mentored numerous students and has held key roles in various scientific committees. She is a member of the Saudi Chemical Association, the Royal Society of Chemistry, and the American Chemical Society. π§βπ¬π©βπ«π¬
Publication Profile
Work Experience ππΌ
Qualifications ππ
Additional Experience ππ¬
Research Focus
Publication Top Notes Β
- Tin versus lead redox chemistry modulates charge trapping and self-doping in tin/lead iodide perovskites (186 citations, 2020) π
- Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents (140 citations, 2015) π
- Inhibition of the Ξ²-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates (41 citations, 2017) π¦
- Direct Access to Ξ±βAminosilanes Enabled by VisibleβLightβMediated Multicomponent Radical CrossβCoupling (36 citations, 2021) π‘
- Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3 H)-ones as β¦ (35 citations, 2015) π¬
- Analysis of Alpina officinarum Hance, chemically and biologically (30 citations, 2019) πΏ
- Combined computational and experimental investigation on the nature of hydrated iodoplumbate complexes: Insights into the dual role of water in perovskite precursor solutions (28 citations, 2020) π§
- The first activation studies of the Ξ·-carbonic anhydrase from the malaria parasite Plasmodium falciparum with amines and amino acids (28 citations, 2018) π¦
- New quinoxalinone inhibitors targeting secreted phospholipase A2 and Ξ±-glucosidase (28 citations, 2017) π§ͺ
- Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach (27 citations, 2021) π¦